Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2020 / Cilt: 53 - Sayı: 1

PERINATAL OUTCOMES OF GESTATIONAL THYROTOXICOSIS: SINGLE CENTER EXPERIENCE, RETROSPECTIVE COHORT

GESTASYONEL TİROTOKSİKOZUN PERİNATAL SONUÇLARI: TEK MERKEZ DENEYİMİ, RETROSPEKTİF KOHORT

Pages
1–5
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A significant positive correlationwas detected between birthweight and TSH and delivery week(p=0.03 r:0.32 and p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE: Gestational thyrotoxicosis may lead to adverse maternaland fetal events.
📊
Key Findings & Data:In this study, the aim was to compare the gestationalthyrotoxicosis cases with the control group in terms of their differentialdiagnoses, clinical observation and gestational follow-up outcomes.MATERIAL AND METHODS: Pregnant patients with subclinicalor overt thyrotoxicosis who were followed up in Endocrinologyoutpatient clinic between December 2009-September 2019 wereincluded in the study.
💡
Conclusion & Impact:A significant positive correlationwas detected between birthweight and TSH and delivery week(p=0.03 r:0.32 and p
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

PURPOSE: Gestational thyrotoxicosis may lead to adverse maternaland fetal events. In this study, the aim was to compare the gestationalthyrotoxicosis cases with the control group in terms of their differentialdiagnoses, clinical observation and gestational follow-up outcomes.MATERIAL AND METHODS: Pregnant patients with subclinicalor overt thyrotoxicosis who were followed up in Endocrinologyoutpatient clinic between December 2009-September 2019 wereincluded in the study. Patients were grouped according to thediagnosis of gestational transient thyrotoxicosis (GTT), Graves’disease, toxic nodular goiter (TNG), and intra-group comparisonsand comparisons with the control group were made in terms of thepresence of perinatalcomplications during the gestational period,delivery week, and birthweight.RESULTS: A total of 115 patients were divided into GTT group,which had 50 patients, Graves’ group, which had 14 patients, TNGgroup, which had 1 patient, and control group, which had 50 patients.The prevalence of hyperemesis gravidarum was the highest in GTTgroup, with 40%. Eclampsia was found in 2 (14.2%) of the pregnantwomen with Graves’ disease and was not found in other groups(p=0.01). Neonatal death was found in 3 (21.4%) of the pregnantwomen with Graves’ disease, and 1 (2%) of the pregnant women withGTT (p=0.01). There was a significant positive correlation betweendelivery week and TSH (p=0.001, r:0.64), and a significant negativecorrelation withft3(p=0.04 r:-0.3). A significant positive correlationwas detected between birthweight and TSH and delivery week(p=0.03 r:0.32 and p

🔖

Cite This Article

KIRNAP, N. G., KAYHAN, S. (2022). PERINATAL OUTCOMES OF GESTATIONAL THYROTOXICOSIS: SINGLE CENTER EXPERIENCE, RETROSPECTIVE COHORT. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 53 - Sayı: 1, 1–5. https://ajindex.com/articles/441229

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. )Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013
  2. 1(3):238-49. 2.)Amino N, Kuro R, Tanizawa O, et al. Changes of serum antithyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin Exp Immunol. 1978
  3. 31(1):30-7. 3.)Glinoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. JCEM. 1990
  4. 71(2):276-87. 4.)Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endoc Rev. 2010
  5. 31(5):702-55. 5.)Lo JC, Rivkees SA, Chandra M, Gonzalez JR, Korelitz JJ, Kuzniewicz MW. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid. 2015
  6. 25(6):698-705. 6.)Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989
  7. 160(1):63-70. 7.)De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. JCEM. 2012
  8. 97(8):2543-65. 8.)Yeo CP, Khoo DH, Eng PH, Tan HK, Yo SL, Jacob E. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol. 2001
  9. 55(3):391-8. 9.)Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007
  10. 110(3):695-703. 10.)Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010
  11. 24(1):13-27. 11.)Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid. 1995
  12. 5(5):425-34. 12.)Lockwood CM, Grenache DG, Gronowski AM. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid. 2009
  13. 19(8):863-8. 13.)Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994
  14. 84(6):946-9. 14.)Laurberg P, Berman DC, Bulow Pedersen I, Andersen S, Carle A. Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt. JCEM. 2012
  15. 97(7):2325-32. 15.)Abraham-Nordling M, Bystrom K, Torring O, et al. Incidence of hyperthyroidism in Sweden. Eur J